✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Madrigal Pharmaceuticals Inc

Common Name
Madrigal Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
528
Ticker
MDGL
Exchange
NASDAQ/NGS
Description
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies targeting major liver diseases. Its primary focus...

Madrigal Pharmaceuticals's Financial Statements Preview

Below are the financial statements of Madrigal Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in thousands of USD
2024 as of 2024-12-31
Assets
Current assets
Cash and cash equivalents
100,019a
Restricted cash
5,000a
Marketable securities
826,232a
Trade receivables, net
53,822a
Inventory
34,068a
Prepaid expenses and other current assets
13,786a
Total current assets
1,032,927a
Property and equipment, net
2,190a
Intangible assets, net
4,729a
Right-of-use asset
2,401a
Total assets
1,042,247a
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
43,599a
Accrued liabilities
124,695a
Lease liability
983a
Total current liabilities
169,277a
Long term liabilities
Loan payable, net of discount
117,569a
Lease liability
1,018a
Total long term liabilities
118,587a
Total liabilities
287,864a
Stockholders’ equity
Preferred stock
0a
Common stock
2a
Additional paid-in-capital
2,556,095a
Accumulated other comprehensive income
468a
Accumulated deficit
-1,802,182a
Total stockholders’ equity
754,383a
Total liabilities and stockholders’ equity
1,042,247a
Limited Data Preview
You are viewing a limited preview of Madrigal Pharmaceuticals’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Madrigal Pharmaceuticals’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Madrigal Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. Madrigal Pharmaceuticals's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?